New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its CEO, Rob Fried, will ...

The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

Meet GHK-Cu, the Copper Peptide Taking Over Your Skincare Feed—Here's Whether It's Worth the Hype ...

The modern morning routine typically begins with a familiar, mechanical ritual that involves stumbling into the kitchen to ...

VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") , a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce ...

Ollie reports that understanding dog food ingredients is crucial for your dog's health, emphasizing nutrient quality over ...

A recent study is raising new questions about whether cannabis-derived compounds could one day play a role in liver care.

An NHS surgeon has named four frozen and tinned fruits and vegetables that can be as or more nutritious than their fresh ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

The Company's Annual General and Special Meeting will be held on Thursday, July 30, 2026, at 11:00 a.m. (Vancouver time), at 15th Floor, 1111 West Hastings Street, Vancouver, British Columbia, with ...